What this Trial Is About

This research aims to evaluate and confirm the usefulness of a new Morphology-Voltage-P-wave Score (MVP Score) in detecting left ventricular diastolic dysfunction in patients with hypertension. The study focuses on adults aged 18 to 70 years who have essential hypertension and investigates how well this score identifies heart function issues related to diastolic dysfunction. Participants will undergo transthoracic echocardiography, a heart ultrasound test, to assess their diastolic function. Researchers will collect various data including demographic details, clinical information, laboratory results, and echocardiography findings. Two investigators will independently gather this information for analysis using specialized statistical software. During the study, participants will be monitored for diastolic dysfunction within one week. The researchers will analyze the collected data to validate the MVP Score's diagnostic accuracy. This process involves detailed heart assessments and thorough data review to understand the score's ability to identify diastolic problems in hypertensive patients.

Validation and Assessment of Novel Morphology-Voltage-P-wave Score for Diagnosing Left Ventricular Diastolic Dysfunction in Patients With Hypertension